Targeted treatment options for opioid-induced constipation (OIC) in global market

• The global opioid-induced constipation market is segmented on the basis of drug type, formulation type, route of administration and end-users
• The global opioid-induced constipation market is expected to reach XX USD Mn by 2024 with a growing CAGR of XX% from 2018 to 2024
• The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
Opioids are prescription drugs taken for treatment of chronic pain. While they relieve the pain, they can give opioid-induced constipation. The adverse effects associated with the opioids are decreasing gastrointestinal tract’s motility, making patient’s strain, and making of solid discharges. Adults are most likely to prone to opioid-induced constipation owing to less immobility, poor diet, and fluid intake.

Request Sample Report: https://bit.ly/2AGAw4r

The opioid-induced constipation treatment market is growing at a significant rate owing to rise in the aging population using opioid analgesics for chronic pains, prolonged usage of opioids in the treatment of pain are anticipated to boost the global opioid-induced constipation drugs market. In addition to this, launching of newer drugs, growing FDA approvals, positive outcomes in clinical trials, and rise in the healthcare expenditure are expected to propel the opioid induced constipation treatment market. However, lack of awareness regarding OIC in patients, a high cost of newer pharmaceuticals, adverse effects, a risk of heart problems and strokes associated with these drugs and unfavorable reimbursement policies expected to hamper the growth of the opioid-induced constipation drugs market.
The global opioid-induced constipation (OIC) treatment market is divided into-

1. Drug type
   • Peripherally restricted μ-opioid receptor antagonists
   • Non-selective opioid antagonists
   • μ -opioid receptor antagonists
   • Locally acting chloride channel activators
2. Type of formulation
   • Solids
   • Semi-solids
   • Liquids
3. Route of administration
   • Oral
   • Parenteral (Subcutaneous Injection)
4. End-users
   • Drugstores, retail pharmacies and hospital pharmacies.
   And lastly, on the basis of geographical regions, global opioid-induced constipation (OIC) drugs market has been categorized into following five regions-North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
   North America holds the largest share in the opioid-induced constipation (OIC) treatment market followed by Europe and Asia-Pacific. North America holds the largest share due to expanding the base of opioid-induced constipation patients.
   Europe accounts for the significant share in the opioid-induced constipation treatment market owing to increased demand for opioid analgesics in various European countries such as UK, France, Spain, Germany etc. However, growing elderly population in India and China, and rise in healthcare spending are creating the huge growth opportunity for the players in Asia-Pacific region.
   Apart from that, Latin America and the Middle East are the potential areas for the growth of opioid-induced constipation treatment market because of the increase in opioid-induced constipation sufferers.
   Some of the key players in the opioid-induced constipation (OIC) drugs market are GlaxoSmithKline plc (U.K.), AstraZeneca U.K), Pfizer Inc. (U.S.), AIKO Biotechnology, Inc. (U.S.), Takeda Pharmaceutical Company Limited (Japan), Boehringer Ingelheim GmbH (Germany), Valeant Pharmaceuticals International Inc. (Canada), Abbott Laboratories (U.S.), and Cosmo Pharmaceuticals N.V. (Ireland) to name a few.
   The global opioid-induced constipation (OIC) treatment market is in the growing stage, several players are actively engaged in the development of the opioid-induced constipation treatment market products. Major acquisitions and collaborations among companies to commercialize opioid-induced constipation drugs market products to drive the market growth. Launching of new products, approval of new drugs from various regulatory bodies, and pipeline products under clinical trials are the key factors helping the growth of the opioid-induced constipation drugs market.
   Key Questions Answered
   • What is the current and future opioids induced constipation treatment market outlook worldwide? What trends are affecting the global market?
   • What is the competitive landscape and market share of major players in the opioids induced constipation treatment market globally?
   • What are the key, high growth markets that opioids induced constipation treatment manufacturers should expand into? Which market segments are growing the fastest?
   • What are the unmet needs with the opioids induced constipation treatment currently on the market? How will emerging technologies fulfil these unmet needs?
   • What is physician perception and market outlook of opioids induced constipation treatment?
   • What are the challenges and barriers that have hindered widespread adoption of opioids induced constipation treatment?
   Reasons to buy opioids induced constipation treatment market Report:
   • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
   • Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
   • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
   • Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses
   • A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
   • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
   • Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

For More Information : https://www.precisionbusinessinsights.com/market-reports/global-opioid-induced-constipation-treatment-market/